Title : Inhibiting poly ADP-ribosylation increases fatty acid oxidation and protects against fatty liver disease.

Pub. Date : 2017 Jan

PMID : 27663419






8 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 METHODS: As poly ADP-ribosylation (PARylation) of proteins by PARPs consumes nicotinamide adenine dinucleotide (NAD+), we hypothesized that overactivation of PARPs drives NAD+ depletion in NAFLD. NAD poly (ADP-ribose) polymerase family, member 1 Mus musculus
2 METHODS: As poly ADP-ribosylation (PARylation) of proteins by PARPs consumes nicotinamide adenine dinucleotide (NAD+), we hypothesized that overactivation of PARPs drives NAD+ depletion in NAFLD. NAD poly (ADP-ribose) polymerase family, member 1 Mus musculus
3 METHODS: As poly ADP-ribosylation (PARylation) of proteins by PARPs consumes nicotinamide adenine dinucleotide (NAD+), we hypothesized that overactivation of PARPs drives NAD+ depletion in NAFLD. NAD poly (ADP-ribose) polymerase family, member 1 Mus musculus
4 METHODS: As poly ADP-ribosylation (PARylation) of proteins by PARPs consumes nicotinamide adenine dinucleotide (NAD+), we hypothesized that overactivation of PARPs drives NAD+ depletion in NAFLD. NAD poly (ADP-ribose) polymerase family, member 1 Mus musculus
5 METHODS: As poly ADP-ribosylation (PARylation) of proteins by PARPs consumes nicotinamide adenine dinucleotide (NAD+), we hypothesized that overactivation of PARPs drives NAD+ depletion in NAFLD. NAD poly (ADP-ribose) polymerase family, member 1 Mus musculus
6 METHODS: As poly ADP-ribosylation (PARylation) of proteins by PARPs consumes nicotinamide adenine dinucleotide (NAD+), we hypothesized that overactivation of PARPs drives NAD+ depletion in NAFLD. NAD poly (ADP-ribose) polymerase family, member 1 Mus musculus
7 Therefore, we assessed the effectiveness of PARP inhibition to replenish NAD+ and activate NAD+-dependent sirtuins, hence improving hepatic fatty acid oxidation. NAD poly (ADP-ribose) polymerase family, member 1 Mus musculus
8 Therefore, we assessed the effectiveness of PARP inhibition to replenish NAD+ and activate NAD+-dependent sirtuins, hence improving hepatic fatty acid oxidation. NAD poly (ADP-ribose) polymerase family, member 1 Mus musculus